A RANDOMIZED TRIAL OF MITOMYCIN/IFOSFAMIDE/CISPLATIN PREOPERATIVE CHEMOTHERAPY PLUS SURGERY VERSUS SURGERY ALONE IN STAGE IIIA NONSMALL CELL LUNG-CANCER

被引：0
|
作者：
ROSELL, R
MAESTRE, J
FONT, A
MORENO, I
MILLA, A
GOMEZCODINA, J
CAMPS, C
MOLINA, F
机构：
[1] UNIV BARCELONA, HOSP BADALONA GERMANS & PUJOL, DEPT THORAC SURG, E-08916 BARCELONA, SPAIN
[2] PLATON CLIN, DEPT RADIOTHERAPY, BARCELONA, SPAIN
[3] HOSP LA FE, DEPT MED ONCOL, VALENCIA, SPAIN
[4] HOSP GEN VALENCIA, DEPT MED ONCOL, VALENCIA, SPAIN
来源：
SEMINARS IN ONCOLOGY | 1994年 / 21卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 33
页数：6
相关论文
共 50 条
  • [21] CHALLENGES OF PREOPERATIVE CHEMOTHERAPY IN NONSMALL CELL LUNG-CANCER
    JOHNSON, DH
    LUNG CANCER, 1994, 10 : S195 - S203
  • [22] A RANDOMIZED TRIAL WITH MITOMYCIN-C IFOSFAMIDE VERSUS MITOMYCIN-C VINDESINE VERSUS CISPLATIN ETOPOSIDE IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    GATZEMEIER, U
    HECKMAYR, M
    HOSSFELD, DK
    KAUKEL, E
    KOSCHEL, G
    NEUHAUSS, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (05): : 405 - 411
  • [23] A RANDOMIZED CLINICAL-TRIAL OF VINDESINE PLUS CISPLATIN VERSUS MITOMYCIN PLUS VINDESINE AND CISPLATIN IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    SHINKAI, T
    EGUCHI, K
    SASAKI, Y
    TAMURA, T
    OHE, Y
    KOJIMA, A
    OSHITA, F
    SAIJO, N
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (05) : 571 - 575
  • [24] COMBINATION CHEMOTHERAPY WITH IFOSFAMIDE, MITOMYCIN, AND CISPLATIN IN ADVANCED NON-SMALL CELL LUNG-CANCER
    GIRON, CG
    ORDONEZ, A
    JALON, JI
    BARON, MG
    CANCER TREATMENT REPORTS, 1987, 71 (09): : 851 - 853
  • [25] Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma
    Danson, S
    Middleton, MR
    O'Byrne, KJ
    Clemons, M
    Ranson, M
    Hassan, J
    Anderson, H
    Burt, PA
    Fairve-Finn, C
    Stout, R
    Dowd, I
    Ashcroft, L
    Beresford, C
    Thatcher, N
    CANCER, 2003, 98 (03) : 542 - 553
  • [26] CISPLATIN ETOPOSIDE VERSUS IFOSFAMIDE ETOPOSIDE COMBINATION CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - A MULTICENTER GERMAN RANDOMIZED TRIAL
    WOLF, M
    HAVEMANN, K
    HOLLE, R
    GROPP, C
    DRINGS, P
    HANS, K
    SCHROEDER, M
    HEIM, M
    DOMMES, M
    MENDE, S
    THIEL, H
    HRUSKA, D
    VICTOR, N
    GEORGII, A
    BRAUN, C
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (12) : 1880 - 1889
  • [27] MITOMYCIN, IFOSFAMIDE AND CISPLATIN IN NON-SMALL-CELL LUNG-CANCER
    CURRIE, DC
    MILES, DW
    DRAKE, JS
    RUDD, R
    SPIRO, SG
    EARL, HM
    HARPER, PG
    TOBIAS, JS
    SOUHAMI, RL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (05) : 380 - 381
  • [28] MITOMYCIN, IFOSFAMIDE AND CISPLATIN IN NON-SMALL CELL LUNG-CANCER
    CULLEN, MH
    CHETIYAWARDANA, AD
    JOSHI, R
    WOODROFFE, CM
    BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 893 - 893
  • [29] MITOMYCIN, IFOSFAMIDE AND CISPLATIN IN NON-SMALL CELL LUNG-CANCER
    CULLEN, MH
    CHETIYAWARDANA, AD
    JOSHI, R
    WOODROFFE, CM
    BRITISH JOURNAL OF CANCER, 1988, 58 (02) : 259 - 259
  • [30] PREOPERATIVE CHEMOTHERAPY FOR LOCALLY ADVANCED NONSMALL CELL LUNG-CANCER
    HOLMES, EC
    RUCKDESCHEL, JC
    SEMINARS IN ONCOLOGY, 1994, 21 (03) : 97 - 100
12345